Home Archive by category "Scientists"

Category: Scientists

Swedish Snuff (Snus), Cigarette Smoking, and Risk of Type 2 Diabetes – American Journal of Preventive Medicine

Introduction Cigarette smoking is a known risk factor for Type 2 diabetes, but evidence regarding former smoking and moist snuff (snus) use and Type 2 diabetes risk is inconclusive. This study investigated the relationships of cigarette smoking and Swedish snus use with the risk of Type 2 diabetes in a cohort of middle-aged and elderly participants. Source: Swedish Snuff (Snus), Cigarette Smoking, and Risk of Type 2 Diabetes – American Journal of Preventive Medicine

Click here to continue!

Potential of Exercise as a COVID-19 Prevention Strategy – American Journal of Preventive Medicine

a woman in a red and white dress sitting outdoors

The coronavirus disease 2019 (COVID-19) pandemic represents one of the greatest threats to population health in more than a century. As of January 2023, >6.7 million deaths globally were attributed to COVID-19. As new mutations evolve, it is apparent that the virus will not be eliminated soon and that strategies for managing life with COVID-19 are needed.1A recent American Journal of Preventive Medicine study shows that exercise and exercise intensity have a strong impact onContinue…

Click here to continue!

NIH VideoCast – Vivek Murthy lecture Series on Public Health leadership

In celebration of Asian American and Native Hawaiian/Pacific Islanders (AANHPI) Heritage Month, join us for the Dr. Vivek H. Murthy Distinguished Lecture Series on Public Health Leadership. This is the third in a series of fireside chats in honor of Dr. Murthy, the 19th and 21st Surgeon General of the United States. The goal of the series is to recognize a public health leader whose enduring efforts have made a significant impact on advancing publicContinue…

Click here to continue!

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2: Trends in Neurosciences

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection has been shown to be associated with a range of neurological complications during the acute and postacute phases.The pathogenesis of SARS-CoV-2-associated CNS disease is complex and diverse, and cannot be explained by one sole mechanism.To understand the pathogenesis of SARS-CoV-2-associated CNS disease, it is important to gain deeper insights into the neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. It is also imperative to consider the kinetics, since a viralContinue…

Click here to continue!

The Potential and Challenges of Mucosal COVID-19 Vaccines | NIH: National Institute of Allergy and Infectious Diseases

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.Although vaccines currently available for COVID-19 are usually effective at preventing severe disease, hospitalizations and death, researchers recognize the need for improvement. A vaccine more effective at preventing transmission or infection with SARS-CoV-2 couldContinue…

Click here to continue!

RFA-AI-23-028: Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to promote basic research to better understand the mechanisms underlying viral invasion of the central nervous system (CNS), virus- and/or host immune-mediated neuropathogenesis, and the associated clinical manifestations for emerging and re-emerging neurotropic viruses. Source: RFA-AI-23-028: Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)

Click here to continue!

Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing

Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, sees something different in his practice since the onset of the COVID-19 pandemic—not just with cancer care, but with cancer itself. Since March 2020, the longtime community oncologist has seen multiple patients in his Rock Hill, South Carolina, based-clinic with cholangiocarcinoma, and these patients are developing the rare cancer 20 to 30 years earlier than the typical age at presentation, which is usually 65Continue…

Click here to continue!

Sharing Multidrug-Resistant Bacteria Between People and Pets… Is There a Concern? | Worms & Germs Blog

An abstract in the upcoming European Conference on Clinical Microbiology and Infectious Diseases (ECCMID) has gotten a fair bit of press and led to a lot of questions because of some sensational headlines. I’ll hopefully be able to check out all the details at ECCMID (I’ll be there for the Global Leaders Group on AMR meeting), but let’s take a quick look at what we know so far… Source: Sharing Multidrug-Resistant Bacteria Between People andContinue…

Click here to continue!

NOT-AI-23-031: Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine

Coccidioidomycosis, more commonly known as Valley fever, is a fungal infection of increasing public health concern in the United States. Clinical manifestations range from mild flu-like disease to severe disseminated infection that can require life-long therapy. Valley fever is most common to the arid regions of the southwestern United States, Mexico and Central and South America. In 2019, more than 20,000 cases were reported to the Centers for Disease Control and Prevention (CDC), and thisContinue…

Click here to continue!